Silvia L Delker - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Structure (London, England : 1993)|March 30, 2021

Structural insights into the function of the catalytically active human Taspase1Nirupa Nagaratnam, Silvia L Delker, Rebecca Jernigan, et al.

Nature Structural & Molecular Biology|August 11, 2014

Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogsPhilip P Chamberlain, Antonia Lopez-Girona, Karen Miller, et al.

Journal of Medicinal Chemistry|November 26, 2024

Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological StudiesKarine G Poullennec, Eric Jnoff, Jan Abendroth, et al.

Bioorganic & Medicinal Chemistry Letters|January 17, 2012

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitorVéronique Plantevin Krenitsky, Lisa Nadolny, Mercedes Delgado, et al.

Plos One|March 24, 2021

Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoebaLogan Tillery, Kayleigh Barrett, Jenna Goldstein, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Structure (London, England : 1993)|March 30, 2021

Structural insights into the function of the catalytically active human Taspase1Nirupa Nagaratnam, Silvia L Delker, Rebecca Jernigan, et al.

Nature Structural & Molecular Biology|August 11, 2014

Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogsPhilip P Chamberlain, Antonia Lopez-Girona, Karen Miller, et al.

Journal of Medicinal Chemistry|November 26, 2024

Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological StudiesKarine G Poullennec, Eric Jnoff, Jan Abendroth, et al.

Bioorganic & Medicinal Chemistry Letters|January 17, 2012

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitorVéronique Plantevin Krenitsky, Lisa Nadolny, Mercedes Delgado, et al.

Plos One|March 24, 2021

Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoebaLogan Tillery, Kayleigh Barrett, Jenna Goldstein, et al.

Pageof 2